Dr. Pooja Patel, director of the epilepsy monitoring unit for Baptist Health Brain & Spine Care, stopped by our studio to ...

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

Biohaven (BHVN) downgraded after FDA setback for VYGLXIA. Learn key risks, pipeline shifts, and what investors should watch ...

Positive topline results announced from Phase 2a clinical trial of RAP-219 in patients with focal onset seizures Phase 2 trial of RAP-219 in bipolar mania enrolling patients and on track, with topline ...

Baergic shareholders eligible to receive up to approximately $82 million in potential development, regulatory, and sales milestones plus a tiered mid-to-high single digit royalty on global net sales f ...

On 5 November 2025, the 8th China International Import Expo (CIIE) opened at the National Exhibition and Convention Center ...

Q3 2025 Earnings Call Transcript November 5, 2025 Operator: “ Jack Khattar: “ Timothy Dec: “ Peter Vozzo: “ Lin Tsai: ” ...

Cannabis is a Schedule I drug, meaning the federal government doesn’t find it to be medically useful. That sentiment isn’t ...

Catalyst Pharmaceuticals CPRX reported adjusted earnings of 68 cents per share for the third quarter of 2025, beating the Zacks Consensus Estimate of 51 cents. The company had recorded adjusted ...